Guerbet phases out 2 contrast agents

French contrast developer Guerbet is phasing out worldwide sales of its Optimark...Read more on AuntMinnie.comRelated Reading: Guerbet invests in French medical technology fund Guerbet sees 7% growth in Q1 revenue Guerbet changes labeling for linear MRI contrast agent Guerbet concurs with gadolinium recommendations Guerbet, Methapharm sign Canadian deal
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news